HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury
- 1 September 2003
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 183 (1) , 47-55
- https://doi.org/10.1016/s0014-4886(03)00080-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titersGene Therapy, 2001
- Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicityGene Therapy, 2000
- Discordance between Expression and Genome Transfer Titering of HSV Amplicon Vectors: Recommendation for Standardized EnumerationMolecular Therapy, 2000
- Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)Neurochemical Research, 2000
- Transplantation of Fetal Kidney Tissue Reduces Cerebral Infarction Induced by Middle Cerebral Artery LigationJournal of Cerebral Blood Flow & Metabolism, 1999
- BCL-2 Transduction, Using a Herpes Simplex Virus Amplicon, Protects Hippocampal Neurons from Transient Global IschemiaExperimental Neurology, 1999
- Interleukin-1 Mediates a Rapid Inflammatory Response After Injection of Adenoviral Vectors into the BrainJournal of Neuroscience, 1999
- Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral arteryNeuroReport, 1998
- In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brainBrain Research, 1997
- A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.Stroke, 1986